Cerevel Therapeutics Holdings Inc (CERE) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cerevel Therapeutics Holdings Inc   (NASDAQ: CERE)


Cerevel Therapeutics Holdings Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cerevel Therapeutics Holdings Inc's ROI in the first quarter of 2024?
Cerevel Therapeutics Holdings Inc recorded a cumulative net loss of $-460 million during 12 months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -44.8%.

Within the Healthcare sector 510 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 0 to 4005.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM 10.18 % 14.17 % 33.05 % 62.61 % 62.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,043 1,496 743 829 867
Return On Investment (TTM) -44.8 % -43.99 % -42.15 % -39.46 % -41.54 %
CERE's Overall Ranking # 4005 # 0 # 3843 # 948 # 2272
Seq. Investment Change TTM 4.47 % 5.52 % -7.23 % 7.74 % 8.24 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -460 -433 -393 -397 -388

CERE Company Profile >> Back to CERE Roi Comparisons >> See Annual CERE Return On Investment



Return On Investment CERE's Ranking
Within: No.
Industry # 217
Sector # 511
Overall # 4005

Return On Investment Statistics
High Average Low
-38.03 %
-107.25 %
-316.66 %
(Jun 30 2023)   (Nov 30 2015)







Financial Statements
Cerevel Therapeutics Holdings Inc's I. Quarter Investments $ 1,043 Millions CERE's Balance sheet
Cerevel Therapeutics Holdings Inc's I. Quarter Income $ -132 Millions Quarterly CERE's Income Statement
CERE's Income by Division See CERE's Income by Division


CERE Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Aug 31 2015)
2015
Total Investments in Millions 1,151 945 646 416 6
Y / Y Investment Growth 21.78 % 46.24 % 55.48 % 6946.19 % -78.7 %
Net Income in Millions -433 -352 -225 -144 -28
Y / Y Net Income Growth - - - - -
Annual Return On Investment -37.6 % -37.19 % -34.86 % -34.73 % -477.22 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CERE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CERE's Competitors
Subscribers only: Roi for Cerevel Therapeutics Holdings Inc's Suppliers
Subscribers only: Return On Investment for CERE's Customers

Other Ratios
CERE's Roa CERE's Inventory Turnover Ratio CERE's Growth Rates CERE's Dividend Statistics
CERE's Profitability Ratios CERE's Asset Turnover Ratio CERE's Dividend Growth
CERE's Roe CERE's Valuation Ratios CERE's Financial Strength Ratios CERE's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-12T06:24:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.